← Leaderboards
Kenneth E Bernstein
Cedars-Sinai Medical Center
$19,603,058
Attributed
$19,603,058
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,603,058 · 12
By mechanism
R01$12,910,788 · 8
P01$3,518,200 · 1
R37$2,366,810 · 1
R21$480,729 · 1
T32$326,531 · 1
Top collaborators
No co-investigators on record.
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Jerome I. Rotter$33,021,712
- Jorge Fernando Giani$1,275,417
- Frank Shih-Chang Ong$102,872
- Everardo Macias$1,373,928
- Dermot Patrick McGovern$11,374,898
Others in their field
Top investigators on “Angiotensin Ii”
- Mohan K. Raizada · University Of Florida$19,287,938
- Kafait U Malik · University Of Tennessee Health Sci Ctr$16,138,278
- David G Harrison · Vanderbilt University Medical Center$15,672,369
- Lisa A Cassis · University Of Kentucky$14,214,826
- Kathryn L Sandberg · Georgetown University$13,815,955
- Sadashiva S. Karnik · Cleveland Clinic Foundation$13,570,529
Research focus
Angiotensin IiCellsPeptidyl-Dipeptidase ABlood PressurePeptidesMacrophageAffectResponseImmune ResponsePhenotypeProductionProteinsInfectionEnzymesInflammatoryPlayLaboratory MouseEnzyme ActivityTranscription FactorAngiotensin-Converting Enzyme InhibitorsBiochemicalPhysiologicalKidneyPeptide Hydrolases
Grant awards (57)
ACE and myeloid cell metabolism$543,615
R01 · FY2025 · AI · contact PI
ACE and myeloid cell metabolism$560,426
R01 · FY2024 · AI · contact PI
ACE and myeloid cell metabolism$338,801
R01 · FY2024 · AI · contact PI
ACE and myeloid cell metabolism$566,378
R01 · FY2023 · AI · contact PI
ACE and myeloid cell metabolism$555,387
R01 · FY2022 · AI · contact PI
Immune effects of ACE over-expression in neutrophils$425,750
R01 · FY2021 · AI · contact PI
The role of angiotensin-converting enzyme in renal inflammation, kidney injury and sodium retention during diabetic nephropathy$425,000
R01 · FY2021 · HL · contact PI
Supplemental Grant: Increased neutrophil function in Alzheimer's disease$334,000
R01 · FY2021 · AI · contact PI
THE ROLE OF ACE IN INFLAMMATION AND HYPERTENSION$699,078
P01 · FY2020 · HL · contact PI
Immune effects of ACE over-expression in neutrophils$425,750
R01 · FY2020 · AI · contact PI
THE ROLE OF ACE IN INFLAMMATION AND HYPERTENSION$699,078
P01 · FY2019 · HL · contact PI
Immune effects of ACE over-expression in neutrophils$425,750
R01 · FY2019 · AI · contact PI
THE ROLE OF ACE IN INFLAMMATION AND HYPERTENSION$699,078
P01 · FY2018 · HL · contact PI
Immune effects of ACE over-expression in neutrophils$443,250
R01 · FY2018 · AI · contact PI
THE ROLE OF ACE IN INFLAMMATION AND HYPERTENSION$699,078
P01 · FY2017 · HL · contact PI
THE ROLE OF ACE IN INFLAMMATION AND HYPERTENSION$721,888
P01 · FY2016 · HL · contact PI
Carboxypeptidase ACE and MHC Class I Presentation$262,500
R21 · FY2016 · AI · contact PI
RAS and Injury$411,237
R01 · FY2015 · HL · contact PI
Carboxypeptidase ACE and MHC Class I Presentation$218,229
R21 · FY2015 · AI · contact PI
RAS and Injury$413,617
R01 · FY2014 · HL · contact PI
RAS and Injury$453,836
R01 · FY2013 · HL · contact PI
RAS and Injury$417,500
R01 · FY2012 · HL · contact PI
RAS and Injury$84,373
R01 · FY2012 · HL · contact PI
RAS and Injury$417,500
R01 · FY2011 · HL · contact PI
RAS and injury: ACE and resistance to cancer and viral infection$323,198
R01 · FY2010 · DK · contact PI
RAS and injury: ACE and resistance to cancer and viral infection$326,463
R01 · FY2009 · DK · contact PI
RAS and injury: ACE and resistance to cancer and viral infection$326,463
R01 · FY2008 · DK · contact PI
Analysis of ACE Knockout Mice$269,732
R01 · FY2008 · DK · contact PI
RAS and injury: ACE and resistance to cancer and viral infection$213,188
R01 · FY2007 · DK · contact PI
Analysis of ACE Knockout Mice$184,080
R01 · FY2007 · DK · contact PI
RAS and injury: ACE and resistance to cancer and viral infection$103,010
R01 · FY2007 · DK · contact PI
Analysis of ACE Knockout Mice$76,038
R01 · FY2007 · DK · contact PI
RENIN/ANGIOTENSIN SYSTEM AND INJURY$361,903
R37 · FY2006 · DK · contact PI
Analysis of ACE Knockout Mice$306,280
R01 · FY2006 · DK · contact PI
RENIN/ANGIOTENSIN SYSTEM AND INJURY$362,088
R37 · FY2005 · DK
Analysis of ACE Knockout Mice$313,650
R01 · FY2005 · DK
RENIN/ANGIOTENSIN SYSTEM AND INJURY$353,816
R37 · FY2004 · DK
Early Cellular Responses to Angiotensin II$249,142
R01 · FY2004 · DK
THE RENAL-SPECIFIC EXPRESSION OF ACE$146,800
R01 · FY2004 · DK
ANALYSIS OF ACE KNOCKOUT MICE$352,810
R01 · FY2003 · DK
RENIN/ANGIOTENSIN SYSTEM AND INJURY$327,553
R37 · FY2003 · DK
Early Cellular Responses to Angiotensin II$241,885
R01 · FY2003 · DK
PATHOBIOLOGY OF MUCOSAL/EPITHELIAL DISEASE$165,832
T32 · FY2003 · DK
THE RENAL-SPECIFIC EXPRESSION OF ACE$148,100
R01 · FY2003 · DK
RENIN/ANGIOTENSIN SYSTEM AND INJURY$386,290
R37 · FY2002 · DK
ANALYSIS OF ACE KNOCKOUT MICE$342,534
R01 · FY2002 · DK
Early Cellular Responses to Angiotensin II$234,840
R01 · FY2002 · DK
PATHOBIOLOGY OF MUCOSAL/EPITHELIAL DISEASE$160,699
T32 · FY2002 · DK
THE RENAL-SPECIFIC EXPRESSION OF ACE$152,000
R01 · FY2002 · DK
ANALYSIS OF ACE KNOCKOUT MICE$332,723
R01 · FY2001 · DK
RENIN/ANGIOTENSIN SYSTEM AND INJURY$262,670
R37 · FY2001 · DK
Early Cellular Responses to Angiotensin II$256,149
R01 · FY2001 · DK
THE RENAL-SPECIFIC EXPRESSION OF ACE$177,083
R01 · FY2001 · DK
ANALYSIS OF ACE KNOCKOUT MICE$331,752
R01 · FY2000 · DK
EARLY CELLULAR RESPONSES TO ANGIOTENSIN 11$260,698
R01 · FY2000 · DK
RENIN/ANGIOTENSIN SYSTEM AND INJURY$256,416
R37 · FY2000 · DK
RENIN/ANGIOTENSIN SYSTEM AND INJURY$56,074
R37 · FY2000 · DK